
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending November 13, 2026.
Catch up on any of the neurology news headlines you may have missed in November 2025, compiled into 1 place by the NeurologyLive® team.
The FDA was busy in November 2025, making a number of decisions on potential new therapeutic agents, including granting approvals and a clearance, issuing a complete response letter, adding a box warning, providing feedback, and reconsidering its stance on a submission.




